3654 results for «386»
3654 results
When STEMI needs assists device
18 May 2023 – From EuroPCR 2023
Learn more about the role of assist devices in STEMI cases in this session: explore the complexities of left and right double culprit STEMI and arrest scenarios, witness the battle between bioresorbable scaffolds and drug-eluting stents in the quest for vascular restoration, uncover the unique challenges...
Shock with valve disease - Part 1
17 May 2023 – From EuroPCR 2023
Discover here some compelling clinical cases on shock and valve disease. Experience real-life scenarios that will help you gain valuable knowledge and improve your clinical decision-making skills.
Complications in the treatment of calcified lesions
18 May 2023 – From EuroPCR 2023
Explore the complexities encountered in the treatment of calcified lesions.
Witness the retrieval of an orbital atherectomy crown using the twisting wire technique, uncover the challenges posed by device entrapment following the use of intravascular lithotripsy, encounter the issue of a stuck OCT catheter and the strategies...
Aortic complications
17 May 2023 – From EuroPCR 2023
Enhance your understanding of managing aortic complications effectively by exploring a comprehensive series of clinical cases presented at EuroPCR. Cases studied include in particular – How to manage iatrogenic aortic dissection during TAVI- Pseudoaneurysm after TAVI, how to close the hole- Aortic dissection following TAVI and...
STEMI and adjunctive theraphy
18 May 2023 – From EuroPCR 2023
Delve into the world of STEMI and adjunctive therapy in this session: explore the potential impact of antiplatelet therapy on achieving an "optimal" angiographic result, gain insights into the considerations surrounding tirofiban and ticagrelor use during pregnancy and delivery, discover the role of cangrelor in the...
Left main and STEMI are not easy
17 May 2023 – From EuroPCR 2023
The management of left main myocardial infarction and ST-segment elevation myocardial infarction (STEMI) can be very challenging and requires careful consideration. Explore a series of difficult situations experienced by your peers and see how they overcame them.
Intervention around arterial hypertension
18 May 2023 – From EuroPCR 2023
Explore the realm of interventions in the context of arterial hypertension in this session: witness the remote haemodynamic monitoring of heritable pulmonary arterial hypertension, uncover the case of unilateral renal atrophy four years after renal sympathetic denervation, break the "boundaries" posed by calcification in renovascular hypertension,...
Pushing TAVI boundaries: daily practice challenges
17 May 2023 – From EuroPCR 2023
Pushing the limits of TAVI is a challenge you face in your daily practice? See how some of your colleagues have tackled the same challenge through this series of cases. To mention a few: TAVR in patient with a large membranous ventricular- Chronic kidney disease and...
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC
08 Apr 2024
Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.
The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease
02 Sep 2025
Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.
Author
